Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
124.4 USD | -0.28% | -0.60% | -11.15% |
Apr. 22 | Bernstein Adjusts Price Target on Illumina to $129 From $150 | MT |
Apr. 22 | Baird Adjusts Price Target on Illumina to $125 From $146, Neutral Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.95% | 19.86B | |
+7.93% | 220B | |
+5.91% | 183B | |
+10.28% | 133B | |
+25.13% | 107B | |
-1.90% | 63.05B | |
+12.28% | 51.74B | |
+3.96% | 50.47B | |
-0.01% | 40.91B | |
+24.83% | 31.91B |
- Stock Market
- Equities
- ILMN Stock
- News Illumina, Inc.
- European Commission Clears Illumina's Proposed Sale of Cancer Test Maker Grail